Chesapeake Asset Management’s GSK GSK Stock Holding History

Chesapeake Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13K	Hold	248	–	–	0.01%	219
2026 Q1	$13.7K	Hold	248	–	–	0.01%	223
2025 Q4	$12.2K	Hold	248	–	–	0.01%	236
2025 Q3	$10.7K	Hold	248	–	–	0.01%	225
2025 Q2	$9.52K	Hold	248	–	–	0.01%	219
2025 Q1	$9.61K	Hold	248	–	–	0.01%	218
2024 Q4	$8.39K	Hold	248	–	–	0.01%	224
2024 Q3	$10.1K	Sell	248 -152	-38%	-$6.22K	0.01%	214
2024 Q2	$15.4K	Hold	400	–	–	0.01%	183
2024 Q1	$17.1K	Sell	400 -209	-34%	-$8.62K	0.02%	171
2023 Q4	$22.6K	Sell	609 -1,200	-66%	-$43.1K	0.02%	178
2023 Q3	$65.6K	Buy	1,809 +156	+9%	+$5.54K	0.06%	125
2023 Q2	$58.9K	Hold	1,653	–	–	0.05%	132
2023 Q1	$58.8K	Buy	+1,653	New	+$57.8K	0.05%	133
2018 Q4	–	Sell	-17,185	Closed	-$863K	–	44
2018 Q3	$863K	Sell	17,185 -84	-0.5%	-$4.27K	0.99%	32
2018 Q2	$870K	Sell	17,269 -792	-4%	-$39.9K	1.01%	32
2018 Q1	$882K	Sell	18,061 -422	-2%	-$19.7K	0.95%	30
2017 Q4	$819K	Sell	18,483 -1,172	-6%	-$54.1K	0.79%	34
2017 Q3	$998K	Sell	19,655 -72	-0.4%	-$3.65K	0.9%	35
2017 Q2	$1.06M	Sell	19,727 -176	-0.9%	-$9.38K	1.01%	32
2017 Q1	$1.05M	Buy	+19,903	New	+$1.01M	0.86%	35
2016 Q4	–	Sell	-45,885	Closed	-$2.47M	–	75
2016 Q3	$2.47M	Hold	45,885	–	–	2.24%	15
2016 Q2	$2.49M	Sell	45,885 -7,680	-14%	-$405K	2.02%	16
2016 Q1	$2.71M	Hold	53,565	–	–	2.25%	19
2015 Q4	$2.7M	Buy	53,565 +26,220	+96%	+$1.34M	2.08%	19
2015 Q3	$1.31M	Hold	27,345	–	–	1.12%	31
2015 Q2	$1.42M	Hold	27,345	–	–	1.05%	33
2015 Q1	$1.58M	Hold	27,345	–	–	1.16%	33
2014 Q4	$1.46M	Buy	+27,345	New	+$1.53M	0.92%	44

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Chesapeake Asset Management's GSK Position: Q2 2026 in Review

Chesapeake Asset Management held its GSK (GSK) position steady in Q2 2026 at 248 shares worth $13K. The position accounts for 0.01% of the portfolio, ranked #219.

Chesapeake Asset Management first reported a position in GSK in Q4 2014 and has held it in 29 quarters since. The position peaked at $2.71M in Q1 2016. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Chesapeake Asset Management held 248 shares of GSK worth $13K as of Q2 2026.
Chesapeake Asset Management left its GSK share count unchanged in Q2 2026.
GSK made up 0.01% of Chesapeake Asset Management's portfolio in Q2 2026, its #219 holding.
Chesapeake Asset Management first reported a position in GSK in Q4 2014 and has held it in 29 quarters since.
Chesapeake Asset Management's GSK position peaked at $2.71M in Q1 2016.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Chesapeake Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.